ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 06 Mar 2023
Last Applicant/ Owned by
201 King of Prussia Road, Suite 501
Radnor
PA
19087
Serial Number
88729361 filed on 16th Dec 2019
Registration Number
N/A
Correspondent Address
Joshua M. Gerben, Esq.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Logo Mark Trademark Information
Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the nature Read More
Classification Information
Class [045]
Personal & Legal & Social Services
Regulatory compliance consulting in the fields of pharmaceuticals, medicines, biopharmaceuticals, and gene therapy
Class [042]
Computer & Software Services & Scientific Services
Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; Scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; Quality control for others; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Material testing; Product quality testing; Scientific laboratory services; Scientific research
Class [040]
Treatment & Processing of Materials Services
Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; Manufacturing process consulting
Mark Details
Serial Number
No 88729361
Mark Type
No Service Mark
Attorney Docket Number
No 07768-0010
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.13.03 -
Incomplete quadrilaterals and quadrilaterals made of broken or dotted lines
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.04 -
Vertical line(s), band(s) or bar(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 06th Mar 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 06th Mar 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 30th Jun 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 28th Jun 2022 | SOU TEAS EXTENSION RECEIVED |
| 28th Jun 2022 | SOU EXTENSION 4 FILED |
| 28th Jun 2022 | SOU EXTENSION 4 GRANTED |
| 28th Jan 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 26th Jan 2022 | SOU TEAS EXTENSION RECEIVED |
| 26th Jan 2022 | SOU EXTENSION 3 FILED |
| 26th Jan 2022 | SOU EXTENSION 3 GRANTED |